Deutsche Bank’s Tenax Therapeutics TENX Stock Holding History

Deutsche Bank’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	-$2K	–	4808
2019 Q4	$2K	Buy	+1	New	+$1.95K	﹤0.01%	4849
2018 Q3	–	Sell	-1	Closed	-$5K	–	5556
2018 Q2	$5K	Buy	+1	New	+$10.1K	﹤0.01%	5254
2018 Q1	–	Hold	0	–	–	–	5593
2017 Q4	–	Hold	0	–	–	–	5133
2017 Q3	–	Hold	0	–	–	–	5076
2017 Q2	–	Hold	0	–	–	–	5110
2017 Q1	–	Sell	-4	Closed	-$145K	–	5097
2016 Q4	$222K	Hold	4	–	–	﹤0.01%	3618
2016 Q3	$261K	Buy	4 +1	+33%	+$78.9K	﹤0.01%	3519
2016 Q2	$237K	Hold	3	–	–	﹤0.01%	3687
2016 Q1	$190K	Hold	3	–	–	﹤0.01%	3685
2015 Q4	$304K	Sell	3 -2	-40%	-$207K	﹤0.01%	3509
2015 Q3	$434K	Hold	5	–	–	﹤0.01%	3439
2015 Q2	$534K	Hold	5	–	–	﹤0.01%	3358
2015 Q1	$471K	Hold	5	–	–	﹤0.01%	3325
2014 Q4	$556K	Hold	5	–	–	﹤0.01%	3601
2014 Q3	$569K	Buy	+5	New	+$642K	﹤0.01%	3404

Other funds holding TENX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank's TENX Position: Q1 2020 in Review

Deutsche Bank sold out of Tenax Therapeutics (TENX) in Q1 2020, closing a stake of 1 share — an estimated $2K sold.

Deutsche Bank first reported a position in TENX in Q3 2014 and held it in 12 quarters. The position peaked at $569K in Q3 2014. 9 funds tracked by Wall St. Rank hold TENX as of Q1 2020.

Deutsche Bank reported no remaining Tenax Therapeutics position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 1 Tenax Therapeutics share in Q1 2020, an estimated $2K.
Deutsche Bank first reported a position in Tenax Therapeutics in Q3 2014 and held it in 12 quarters.
Deutsche Bank's Tenax Therapeutics position peaked at $569K in Q3 2014.
9 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.